Mechanisms of immune response to inorganic nanoparticles and their degradation products
- 2 November 2021
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 180, 114022
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- ALSAM Foundation
This publication has 186 references indexed in Scilit:
- Silica nanoconstruct cellular toleration threshold in vitroJournal of Controlled Release, 2011
- Pulmonary response to surface‐coated nanotitanium dioxide particles includes induction of acute phase response genes, inflammatory cascades, and changes in microRNAs: A toxicogenomic studyEnvironmental and Molecular Mutagenesis, 2011
- Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF NanomedicineClinical Cancer Research, 2010
- Activation of human neutrophils by titanium dioxide (TiO2) nanoparticlesToxicology in Vitro, 2010
- Particle length-dependent titanium dioxide nanomaterials toxicity and bioactivityParticle and Fibre Toxicology, 2009
- Epigenetics: Definition, Mechanisms and Clinical PerspectiveSeminars in Reproductive Medicine, 2009
- Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacyVaccine, 2009
- From endoplasmic-reticulum stress to the inflammatory responseNature, 2008
- Mitochondrial Membrane Permeabilization in Cell DeathPhysiological Reviews, 2007
- Epigenetics in human disease and prospects for epigenetic therapyNature, 2004